Showing results (11-20 of 610) with videos related to
Sort By:
Pageof 61
Bailliere'S Clinical Haematology|June 1, 1995
Mechanisms of physiological fibrinolysisH R Lijnen, D CollenBailliere'S Clinical Haematology|June 1, 1995
New thrombolytic agents and strategiesD Collen, H R LijnenThrombosis and Haemostasis|July 1, 1995
Molecular basis of fibrinolysis, as relevant for thrombolytic therapyD Collen, H R LijnenArteriosclerosis (Dallas, Tex.)|November 1, 1984
New approaches to thrombolytic therapyD Collen, H R LijnenBlood|May 1, 1986
A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusionP Holvoet, H R Lijnen, D CollenCirculation Research|May 4, 2002
Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) geneJ Silence, D Collen, H R LijnenThrombosis Research|August 1, 1984
Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitroC Zamarron, H R Lijnen, D CollenThrombosis and Haemostasis|August 28, 2001
Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1M Dewerchin, D Collen, H R LijnenPageof 61